{"gene":"TAB2","run_date":"2026-06-10T10:51:54","timeline":{"discoveries":[{"year":2000,"finding":"TAB2 is an adaptor protein that physically links TAK1 to TRAF6 in the IL-1 signaling pathway. IL-1 stimulation induces translocation of TAB2 from the membrane to the cytosol, where it mediates IL-1-dependent association of TAK1 with TRAF6, leading to TAK1 activation and downstream JNK and NF-κB activation. Dominant-negative TAB2 impairs JNK and NF-κB activation by IL-1.","method":"Co-immunoprecipitation, dominant-negative overexpression, subcellular fractionation","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, dominant-negative functional rescue, subcellular localization with functional consequence; foundational paper replicated extensively","pmids":["10882101"],"is_preprint":false},{"year":2001,"finding":"IRAK is required for IL-1-induced TAB2 translocation from the membrane to the cytosol. In IRAK-deficient cells, TAB2 translocation and its association with TRAF6 are abolished, preventing formation of the TRAF6-TAB2-TAK1 complex and TAK1 activation.","method":"IRAK-deficient cell lines, subcellular fractionation, co-immunoprecipitation","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function (IRAK-deficient cells), co-IP, localization assay with defined phenotype; replicated by independent lab (PMID:11518704)","pmids":["11259596","11518704"],"is_preprint":false},{"year":2002,"finding":"In IL-1 signaling, IRAK recruits TRAF6 to a membrane complex (complex I), which then associates with pre-formed TAK1-TAB1-TAB2 on the membrane (complex II). This leads to phosphorylation of TAK1 and TAB2 on the membrane, followed by dissociation of the TRAF6-TAK1-TAB1-TAB2 complex (complex III) and translocation to the cytosol where TAK1 is activated.","method":"Sequential co-immunoprecipitation, subcellular fractionation, phosphorylation assays with IRAK-deficient cells","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal biochemical methods, genetic loss-of-function, clear mechanistic dissection of complex assembly/disassembly","pmids":["12242293"],"is_preprint":false},{"year":2002,"finding":"TAK1 and TAB2 participate in the RANK signaling pathway. RANKL stimulation promotes formation of a complex containing RANK, TRAF6, TAB2, and TAK1, leading to TAK1 activation. Dominant-negative TAB2 inhibits NF-κB activation induced by RANK overexpression and by RANKL in monocyte RAW264.7 cells.","method":"Co-immunoprecipitation in RANK-stably transfected 293 cells, dominant-negative overexpression, kinase assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP, dominant-negative functional assay, two cell-line systems","pmids":["11809792"],"is_preprint":false},{"year":2003,"finding":"TLR3-mediated NF-κB and MAP kinase activation proceeds through an IRAK-independent pathway in which TRAF6, TAK1, and TAB2 are recruited to the TLR3 receptor to form a complex that translocates to the cytosol where TAK1 is phosphorylated and activated. PKR is also detected in this TAK1 complex.","method":"IRAK-deficient cell lines, co-immunoprecipitation, subcellular fractionation, dominant-negative kinase assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function lines, co-IP, biochemical fractionation with two orthogonal functional readouts","pmids":["12609980"],"is_preprint":false},{"year":2003,"finding":"TAB2-deficient mouse embryonic fibroblasts do not show impaired IL-1-induced NF-κB or MAP kinase activation, demonstrating that TAB2 alone is not essential for IL-1 signaling in fibroblasts. However, TAB2 knockout is embryonic lethal due to liver degeneration and apoptosis, indicating an essential anti-apoptotic role in fetal liver.","method":"TAB2 knockout mouse generation, embryonic fibroblast NF-κB activation assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knockout mouse with specific phenotypic readout, replicated by independent group (PMID:16260493)","pmids":["12556483"],"is_preprint":false},{"year":2003,"finding":"TAB3, a TAB2-like molecule, associates with TAK1 and activates NF-κB. Endogenous TAB3 interacts with TRAF6 and TRAF2 in an IL-1- and TNF-dependent manner, respectively. IL-1 signaling leads to ubiquitination of TAB2 and TAB3 through TRAF6. siRNA knockdown of both TAB2 and TAB3 (but not either alone) inhibits IL-1- and TNF-induced TAK1 and NF-κB activation, showing functional redundancy.","method":"siRNA double knockdown, co-immunoprecipitation, ubiquitination assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — siRNA knockdown with specific signaling readouts, co-IP, ubiquitination assay; establishes redundancy with TAB3","pmids":["14633987"],"is_preprint":false},{"year":2004,"finding":"TAB2 and TAB3 bind preferentially to lysine 63-linked polyubiquitin chains through a conserved C-terminal zinc finger (NZF/ZnF) domain. Mutations of the ZnF domain abolish polyubiquitin binding and the ability to activate TAK1 and IKK. Replacement of the ZnF domain with a heterologous ubiquitin-binding domain restores TAK1 and IKK activation. TAB2 binds to polyubiquitinated RIP following TNF-α stimulation.","method":"In vitro ubiquitin-binding assay, site-directed mutagenesis, domain swap experiments, co-immunoprecipitation","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro binding assay with mutagenesis, domain swap rescue experiment, co-IP; multiply replicated foundational mechanism paper","pmids":["15327770"],"is_preprint":false},{"year":2004,"finding":"TAB2 is involved in the phosphorylation of TAK1 at Thr-187 in the activation loop during TNF-α stress. TAB1 and TAB2 regulate TAK1 Thr-187 phosphorylation differentially. TAB2 is part of the TAK1 signaling complex required for stress-induced rapid and transient TAK1 activation.","method":"Phospho-specific antibody, RNA interference, overexpression experiments, kinase assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — phospho-specific antibody with RNAi and overexpression, single lab, two orthogonal methods","pmids":["15590691"],"is_preprint":false},{"year":2005,"finding":"TAK1 (but not TAB1 or TAB2 alone) is essential for TNFR1-, IL-1R-, TLR3-, and TLR4-mediated NF-κB and AP-1 activation in embryonic fibroblasts. Tab1(-/-) and Tab2(-/-) fibroblasts show normal NF-κB and AP-1 responses, confirming the redundant/dispensable roles of TAB1 and TAB2 in these contexts.","method":"Conditional knockout mouse embryonic fibroblasts, NF-κB luciferase assays, kinase assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic knockout with multiple signaling readouts across multiple receptor systems","pmids":["16260493"],"is_preprint":false},{"year":2005,"finding":"TAB2, TRAF6, and TAK1 are components of the Edar/Edaradd NF-κB signaling pathway. TAB2 was identified as a binding partner of Edaradd by yeast two-hybrid; endogenous TAB2, TRAF6, and TAK1 co-immunoprecipitate with Edaradd. Dominant-negative TAB2, TRAF6, and TAK1 block NF-κB activation by Edaradd.","method":"Yeast two-hybrid, co-immunoprecipitation, dominant-negative functional assay","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid plus co-IP plus dominant-negative assay, single lab","pmids":["16251197"],"is_preprint":false},{"year":2005,"finding":"Drosophila TAB2 (dTAB2) links dTRAF1 to the JNKKK dTAK1, functioning as an adaptor in the TNF/Eiger-JNK pathway. Genetic epistasis and biochemical protein-protein interaction assays establish dTAB2 as an essential component of this conserved signaling module.","method":"Genetic screen, epistasis analysis, protein-protein interaction assay","journal":"Genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis plus biochemical interaction assay in Drosophila ortholog, single lab","pmids":["16079232"],"is_preprint":false},{"year":2006,"finding":"The TAB2/TAB3-binding domain in TAK1 maps to a non-contiguous region in the last C-terminal 100 residues (residues 479–553 are necessary and sufficient). Residues 574–693 of TAB2 interact with TAK1. A peptide (TAK1-C100) that disrupts TAB2/TAB3-TAK1 interaction abolishes TAK1 phosphorylation and IKK/MAPK activation by IL-1, TNF, and RANKL, and blocks RANKL-induced osteoclast differentiation.","method":"Deletion mapping, co-immunoprecipitation, dominant-negative peptide, kinase assays, osteoclast differentiation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — systematic domain mapping with co-IP, dominant-negative functional assays across multiple stimuli, two orthogonal readouts","pmids":["17158449"],"is_preprint":false},{"year":2007,"finding":"Smad7 binds directly to TAB2 and TAB3, competing with TAK1 binding and blocking recruitment of TAK1 to TRAF2 in the TNF signaling pathway. Smad7-TAB2/TAB3 complex formation suppresses TNF-induced NF-κB activation. Transgenic Smad7 in mouse skin disrupts endogenous TRAF2-TAK1-TAB2 complex formation.","method":"Co-immunoprecipitation, in vitro binding assay, transgenic mouse model, NF-κB reporter assays","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vitro binding, co-IP, transgenic in vivo confirmation; multiple orthogonal methods","pmids":["17384642"],"is_preprint":false},{"year":2007,"finding":"HTLV-1 Tax physically interacts with TAB2; TAB2 and Tax cooperatively activate TAK1, and TAK1 activation by Tax requires TAB2 binding as well as ubiquitination of Tax. Tax-induced overexpression of TAB2 (but not TAB3) leads to constitutive TAK1 activation, which drives JNK-ATF2 but not IKK-NF-κB signaling.","method":"Co-immunoprecipitation, siRNA knockdown, kinase assays, reporter assays","journal":"The Journal of biological chemistry / Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus kinase assays plus reporter, two independent papers (PMIDs 17626013, 17986383) with similar conclusions","pmids":["17626013","17986383"],"is_preprint":false},{"year":2008,"finding":"TRIM30α promotes degradation of TAB2 and TAB3 through its RING domain E3 ubiquitin ligase activity. TRIM30α interacts with the TAB2-TAB3-TAK1 complex and negatively regulates TLR-mediated NF-κB activation via this degradation. Expression of TRIM30α is itself NF-κB-dependent, forming a negative feedback loop.","method":"Co-immunoprecipitation, protein degradation assay, siRNA knockdown, transgenic mouse, NF-κB reporter","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — co-IP, degradation assay, in vivo transgenic and siRNA knockdown, multiple orthogonal methods","pmids":["18345001"],"is_preprint":false},{"year":2008,"finding":"NUMBL interacts with TAB2 via its PTB domain. NUMBL overexpression inhibits TNF-α- and IL-1β-induced NF-κB activation and impairs TAB2 binding to TRAF6 or RIP, and inhibits TRAF6 ubiquitination enhanced by TAB2.","method":"Yeast two-hybrid, co-immunoprecipitation (in vitro and in vivo), NF-κB reporter, ubiquitination assay","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid plus reciprocal co-IP plus functional assay, single lab","pmids":["18299187"],"is_preprint":false},{"year":2009,"finding":"Crystal structures of the TAB2 NZF domain bound to K63-linked di- and triubiquitin reveal that TAB2 binds adjacent ubiquitin moieties via two distinct binding sites. Both sites recognize the Ile44-centered hydrophobic patch on ubiquitin but do not contact the K63 isopeptide bond. The conformational constraints imposed by TAB2 on K63 dimers cannot be adopted by linear chains, explaining selectivity for K63 over linear ubiquitin chains.","method":"X-ray crystallography, mutagenesis of binding sites, ubiquitin-binding assay","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution crystal structures plus mutagenesis validation, independently confirmed by PMID:19927120","pmids":["19935683"],"is_preprint":false},{"year":2009,"finding":"Crystal structures of TAB2 and TAB3 NZF domains in complex with K63-linked diubiquitin at 1.18 and 1.40 Å resolution confirm two-site binding: distal ubiquitin recognized via conserved Thr-Phe dipeptide; proximal ubiquitin via a surface specific to TAB2/TAB3. Mutagenesis shows both sites are required for K63-linked diubiquitin binding.","method":"X-ray crystallography, mutagenesis, ubiquitin-binding assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution crystal structures with mutagenesis validation, corroborates PMID:19935683","pmids":["19927120"],"is_preprint":false},{"year":2009,"finding":"TAB2 was identified as a direct binding partner of RCAN1 by yeast two-hybrid. TAB2 recruits TAK1, TAB1, and calcineurin, forming a macromolecular signaling complex. TAK1 (activated via TAB1 and TAB2) phosphorylates RCAN1 at Ser94 and Ser136, converting RCAN1 from an inhibitor to a facilitator of calcineurin-NFAT signaling. In Tab2-deficient MEFs, the TAK1-TAB1-TAB2 and calcineurin-NFAT modules do not interact.","method":"Yeast two-hybrid, co-immunoprecipitation, in vitro kinase assay, site-directed mutagenesis, Tab2-deficient MEFs","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — yeast two-hybrid, in vitro kinase reconstitution, mutagenesis, genetic loss-of-function; multiple orthogonal methods in one rigorous study","pmids":["19136967"],"is_preprint":false},{"year":2010,"finding":"TAB2 functions as a scaffold protein that directly interacts with NLK and bridges TAK1 to NLK. The intermediate region (residues 292–417) of TAB2 is required for NLK binding. TAB2 mediates TAK1-dependent NLK activation and LEF1 polyubiquitylation, resulting in inhibition of canonical Wnt/β-catenin signaling. Wnt3a stimulation increases TAB2-NLK interaction and promotes TAK1-TAB2-NLK complex formation.","method":"Co-immunoprecipitation, siRNA knockdown, deletion mutant analysis, luciferase reporter assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with domain mapping, siRNA with functional readout, single lab","pmids":["20194509"],"is_preprint":false},{"year":2011,"finding":"Beclin 1 constitutively interacts with TAB2 and TAB3 via their coiled-coil domains. Upon autophagy induction, TAB2 and TAB3 dissociate from Beclin 1 and bind TAK1. Overexpression of TAB2/TAB3 suppresses autophagy, while their depletion triggers autophagy. This defines an autophagy-stimulatory switch where TAB2/TAB3 abandon inhibitory interactions with Beclin 1 to engage TAK1.","method":"Co-immunoprecipitation, siRNA knockdown, autophagy assays, domain mapping (coiled-coil domain)","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — co-IP, domain mapping, siRNA/overexpression with autophagy functional readouts; multiple orthogonal methods","pmids":["22081109"],"is_preprint":false},{"year":2011,"finding":"TAB2 interaction with TAK1 attenuates the ASK1-TAK1 interaction through competitive binding at the C-terminal TAB2-binding domain of TAK1, thereby reciprocally regulating both TAK1-NF-κB and ASK1-AP-1 signaling pathways.","method":"Co-immunoprecipitation, competitive binding assays, kinase assays, reporter assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with competition assay and functional reporter assay, single lab","pmids":["22167179"],"is_preprint":false},{"year":2013,"finding":"TAB2 undergoes SUMOylation at the conserved lysine 329, mediated by the SUMO E3 ligase PIAS3. Mutation of K329 blocks SUMOylation and enhances TAB2 activity as measured by AP-1 luciferase reporter assays, indicating that SUMOylation negatively regulates TAB2 activity.","method":"SUMOylation assay, Ubc9 fusion analysis, site-directed mutagenesis (K329), co-immunoprecipitation with PIAS3, AP-1 reporter","journal":"Molecular and cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis of SUMOylation site with functional readout, co-IP with E3 ligase, single lab","pmids":["24096733"],"is_preprint":false},{"year":2014,"finding":"TRIM38 constitutively interacts with TAB2 and TAB3 and promotes their lysosome-dependent degradation, independent of TRIM38's E3 ubiquitin ligase activity. TRIM38 deficiency abolishes TAB2 translocation to the lysosome, increases TAB2 levels, and enhances TAK1 activation after TNF-α and IL-1β stimulation.","method":"Co-immunoprecipitation, lysosomal inhibitor assays, TRIM38 knockout cells, TRIM38 RING-domain mutant","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — co-IP, lysosomal pathway assay, knockout cells with specific kinase activation readout, domain mutant; multiple orthogonal methods","pmids":["24434549"],"is_preprint":false},{"year":2014,"finding":"Enterovirus 71 3C protease cleaves TAB2 at Q113-S114, requiring protease activity (abolished by H40D or C147S active-site substitutions). 3C interacts with TAB2 and TAK1, inhibiting NF-κB activation. Overexpression of TAB2 inhibits EV71 replication, while cleaved fragments have no effect.","method":"Co-immunoprecipitation, protease active-site mutagenesis, cleavage-site mapping, overexpression rescue assay","journal":"Journal of virology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — active-site mutagenesis, cleavage-site mapping, functional rescue experiment; single lab but multiple orthogonal methods","pmids":["24942571"],"is_preprint":false},{"year":2015,"finding":"RBCK1 physically interacts with TAB2 and TAB3 and facilitates their degradation through a proteasome-dependent process, negatively regulating TNF- and IL-1-induced NF-κB activation.","method":"Co-immunoprecipitation, proteasome inhibitor assay, siRNA knockdown, NF-κB reporter","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus proteasomal degradation assay plus siRNA functional readout, single lab","pmids":["17449468"],"is_preprint":false},{"year":2015,"finding":"RNF4 interacts with the TAK1-TAB2-TAB3 complex (but not TAB1) and specifically down-regulates TAB2 through a lysosomal pathway, negatively regulating NF-κB signaling.","method":"Co-immunoprecipitation, lysosomal inhibitor assay, siRNA knockdown, NF-κB reporter","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, lysosomal pathway assay, siRNA functional readout; single lab","pmids":["26299341"],"is_preprint":false},{"year":2015,"finding":"TRIM22 interacts with TAB2 and promotes its degradation, negatively regulating the TRAF6-stimulated NF-κB pathway. The RING domain of TRIM22 is required for these effects.","method":"Co-immunoprecipitation, protein degradation assay, RING-domain deletion mutant, NF-κB reporter","journal":"Virologica Sinica","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, domain mutant, degradation assay with functional readout; single lab","pmids":["23818111"],"is_preprint":false},{"year":2016,"finding":"TAB2 interacts with estrogen receptor alpha (ERα) through a central domain (residues adjacent to MEKK1 phosphorylation sites, distinct from the NZF and CUE domains). This interaction dismisses NCoR corepressor from ERα on target gene regulatory regions, contributing to tamoxifen resistance. siRNA knockdown of TAB2 restores antiproliferative response to tamoxifen in resistant breast cancer cells.","method":"Co-immunoprecipitation, pull-down with recombinant proteins, competition assay, domain mapping, siRNA knockdown, cell proliferation assay","journal":"PloS one / Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — recombinant protein pull-down with domain mapping, siRNA functional assay; two papers from same lab","pmids":["27992601","22249258"],"is_preprint":false},{"year":2017,"finding":"IL-1β can activate the TAB1-TAK1 heterodimer in TAB2/TAB3 double knockout cells, but this activation requires TRAF6 expression and Ubc13 (K63-Ub chain synthesis). In TAB2/3 DKO cells, early NF-κB and p38α activation is normal but is transient, and JNK1/2 and p38γ activation is greatly reduced. An ubiquitin-binding-defective mutant of TAB2 cannot restore signaling to TAB1/2/3 triple KO cells, confirming that K63-Ub chain binding by TAB2 is required for sustained/full TAK1 signaling.","method":"TAB2/TAB3 double knockout cells, TAB1/2/3 triple knockout cells, ubiquitin-binding mutant reconstitution, kinase assays, siRNA knockdown","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic knockouts, ubiquitin-binding mutant rescue, kinase assays with multiple pathway readouts; systematic mechanistic dissection","pmids":["28507161"],"is_preprint":false},{"year":2019,"finding":"Multiple GPCR agonists (thrombin, histamine) activate p38 MAPK via a non-canonical, TAB1-TAB2-dependent pathway (rather than canonical MKK3/6) in endothelial cells. In different endothelial cell types, either TAB1-TAB2 or TAB1-TAB3, or both, are required for GPCR-stimulated p38 autophosphorylation and IL-6 production.","method":"siRNA knockdown of TAB1, TAB2, TAB3; phosphorylation assays; IL-6 production assay; multiple endothelial cell types","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown with multiple cell types and phosphorylation readouts, single lab","pmids":["30760523"],"is_preprint":false},{"year":2020,"finding":"USP15 deubiquitinates K48-linked ubiquitin chains from TAB2 (and independently inhibits lysosome-associated TAB2 degradation via a deubiquitinase-independent mechanism), thereby stabilizing TAB2, enhancing TAK1-TAB complex integrity, and potentiating NF-κB activation following TNF-α and IL-1β stimulation.","method":"Co-immunoprecipitation, deubiquitination assay, lysosomal inhibitor assay, siRNA knockdown/overexpression, NF-κB reporter","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — deubiquitination assay, co-IP, dual-pathway degradation assay; single lab but multiple orthogonal methods","pmids":["31903660"],"is_preprint":false},{"year":2021,"finding":"Crystal structure of TAB2 NZF in complex with K6-linked diubiquitin at 1.99 Å resolution reveals that TAB2-NZF simultaneously contacts distal and proximal ubiquitin moieties of K6-Ub2. Structural comparison with K63-Ub2 complex shows similar binding mechanism except for flexibility in the C-terminal region of the distal ubiquitin, which accounts for dual K6/K63 specificity.","method":"X-ray crystallography, structural comparison, mutagenesis","journal":"Biophysical journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — high-resolution crystal structure with structural comparison to previously solved K63 complex; single lab","pmids":["34242591"],"is_preprint":false},{"year":2022,"finding":"Cardiomyocyte-specific deletion of TAB2 (but not TAB3) in mice causes dilated cardiomyopathy with massive apoptotic and necroptotic cell death. TAB2 critically mediates RIPK1 phosphorylation at Ser321 via a TAK1-dependent mechanism, preventing RIPK1 kinase activation and formation of RIPK1-FADD-caspase-8 apoptotic and RIPK1-RIPK3 necroptotic complexes. Genetic inactivation of RIPK1 (Ripk1-K45A knockin) rescues cardiac remodeling in Tab2-deficient mice.","method":"Cardiomyocyte-specific TAB2 knockout, RIPK1 phosphorylation assay, RIPK1-K45A knockin rescue, complex immunoprecipitation, apoptosis/necroptosis assays","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout with TAK1 activation rescue, RIPK1 phosphorylation assay, genetic rescue with RIPK1-K45A knockin; multiple orthogonal in vivo and in vitro methods","pmids":["34990405"],"is_preprint":false},{"year":2023,"finding":"USP25 deubiquitinates K63-specific polyubiquitin chains from TAB2, restricting NF-κB and MAPK signaling activation. AAV9-mediated TAB2 knockdown ameliorates ischemic stroke injury and abolishes the effect of USP25 deletion, placing USP25-TAB2 axis in neuroinflammatory regulation.","method":"Co-immunoprecipitation, K63-deubiquitination assay, AAV9-mediated knockdown in vivo, NF-κB/MAPK signaling assays","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — deubiquitination assay, in vivo AAV9 knockdown rescue, co-IP; single lab","pmids":["37587766"],"is_preprint":false},{"year":2023,"finding":"RNF99 promotes K48-linked ubiquitination of TAB2 at lysine 611, leading to proteasomal degradation of TAB2 and negative regulation of TLR-mediated NF-κB and MAPK signaling. RNF99 knockout mice show enhanced TLR-mediated cytokine production.","method":"Co-immunoprecipitation, K48-ubiquitination assay, site-directed mutagenesis (K611), RNF99 knockout mouse, proteasomal inhibitor assay","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 / Strong — site-specific ubiquitination mutagenesis, knockout mouse, proteasomal pathway assay, multiple orthogonal methods","pmids":["36681779"],"is_preprint":false},{"year":2024,"finding":"TAB2 and TAB3 are redundantly required for TLR-mediated cytokine production (TNF-α, IL-6) in macrophages. TAB2/TAB3 double-deficient macrophages show significantly impaired NF-κB and MAPK pathway activation, and severely compromised IκBζ expression at both protein and mRNA levels, thereby impeding IL-6 production.","method":"TAB2/TAB3 double knockout macrophages (improved mouse model), cytokine assays, NF-κB and MAPK signaling assays, IκBζ expression analysis","journal":"International immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — improved double knockout model with multiple signaling readouts; directly addresses and resolves prior conflicting result","pmids":["38567483"],"is_preprint":false},{"year":2025,"finding":"LSDV001 viral protein interacts with TAK1 and TAB2/TAB3 and promotes assembly of the TAK1-TAB2/3 complex, leading to enhanced IKK-dependent NF-κB activation and inflammatory cytokine induction. LSDV001-deficient virus has attenuated NF-κB activation and reduced pathology.","method":"Co-immunoprecipitation, NF-κB reporter, virus deletion mutant (LSDVΔ001), in vivo infection model","journal":"mBio","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, viral deletion mutant with functional readout and in vivo phenotype; single lab","pmids":["40852992"],"is_preprint":false}],"current_model":"TAB2 is a scaffold/adaptor protein that bridges the upstream ubiquitin-signaling machinery to the kinase TAK1 by binding K63- (and K6-) linked polyubiquitin chains through its C-terminal NZF zinc-finger domain, thereby recruiting and activating the TAK1 kinase complex downstream of IL-1R, TNFR, TLRs, RANK, and other immune receptors to drive NF-κB, JNK, and p38 MAPK signaling; TAB2 additionally inhibits autophagy by sequestering Beclin 1, scaffolds TAK1-NLK for Wnt pathway repression, mediates RIPK1 phosphorylation at Ser321 to suppress cardiomyocyte necroptosis/apoptosis, and interacts with estrogen receptor α to modulate corepressor dismissal, while its activity and stability are regulated by multiple E3 ubiquitin ligases (TRIM30α, TRIM38, RBCK1, RNF4, RNF99) and deubiquitinases (USP15, USP25) that target it for proteasomal or lysosomal degradation."},"narrative":{"mechanistic_narrative":"TAB2 is a ubiquitin-binding scaffold/adaptor protein that couples upstream immune-receptor signaling to activation of the kinase TAK1, driving NF-κB, JNK, and p38 MAPK responses downstream of IL-1R, TNFR, TLRs, RANK, and Edar [PMID:10882101, PMID:11809792, PMID:12609980, PMID:16251197]. Upon IL-1 stimulation, TAB2 translocates from the membrane to the cytosol in an IRAK-dependent manner and bridges TAK1 to TRAF6, nucleating the TRAF6–TAK1–TAB1–TAB2 complex whose assembly and disassembly govern TAK1 activation [PMID:10882101, PMID:11259596, PMID:11518704, PMID:12242293]. The central mechanistic basis is the C-terminal NZF zinc-finger domain, which binds preferentially to K63- (and K6-) linked polyubiquitin chains; crystal structures show two-site recognition of adjacent ubiquitin moieties via the Ile44 hydrophobic patch, with conformational constraints that select against linear chains, and mutations abolishing ubiquitin binding eliminate TAK1/IKK activation [PMID:15327770, PMID:19935683, PMID:19927120, PMID:34242591]. TAB2 is functionally redundant with its paralog TAB3: single deletion leaves IL-1/TNF signaling largely intact, whereas combined loss impairs sustained TAK1, NF-κB, and MAPK activation, IκBζ expression, and macrophage cytokine production, with K63-ubiquitin binding by TAB2 required for full/sustained signaling [PMID:14633987, PMID:16260493, PMID:28507161, PMID:38567483]. Beyond canonical inflammatory signaling, TAB2 scaffolds TAK1 to NLK to repress Wnt/β-catenin signaling [PMID:20194509], sequesters Beclin 1 to restrain autophagy until TAB2/TAB3 switch to engage TAK1 [PMID:22081109], and in cardiomyocytes mediates TAK1-dependent RIPK1 Ser321 phosphorylation that prevents apoptotic and necroptotic cell death; cardiomyocyte-specific TAB2 loss causes dilated cardiomyopathy rescued by RIPK1 kinase inactivation [PMID:34990405]. TAB2 abundance and activity are tightly controlled by E3 ligases driving proteasomal or lysosomal degradation (TRIM30α, TRIM38, RBCK1, RNF4, TRIM22, RNF99) and by deubiquitinases (USP15, USP25) that stabilize it and potentiate signaling [PMID:18345001, PMID:24434549, PMID:17449468, PMID:26299341, PMID:23818111, PMID:31903660, PMID:37587766, PMID:36681779].","teleology":[{"year":2000,"claim":"Established TAB2 as the adaptor that physically links TAK1 to TRAF6 in IL-1 signaling, defining its core scaffolding role in NF-κB/JNK activation.","evidence":"Co-IP, dominant-negative overexpression, and subcellular fractionation in IL-1-stimulated cells","pmids":["10882101"],"confidence":"High","gaps":["Did not define the molecular determinant of the TRAF6 interaction","Did not establish whether the link is direct or ubiquitin-mediated"]},{"year":2002,"claim":"Resolved the temporal order of complex assembly, showing IRAK-dependent membrane recruitment of TRAF6 to pre-formed TAK1-TAB1-TAB2 followed by phosphorylation and cytosolic translocation.","evidence":"Sequential co-IP, subcellular fractionation, and phosphorylation assays in IRAK-deficient cells","pmids":["11259596","12242293"],"confidence":"High","gaps":["Did not identify the signal triggering complex dissociation","Phosphorylation sites on TAB2 not mapped"]},{"year":2002,"claim":"Extended TAB2's adaptor role beyond IL-1R to RANK signaling, generalizing it across immune receptors.","evidence":"Co-IP and dominant-negative kinase assays in RANK-transfected and RAW264.7 cells","pmids":["11809792"],"confidence":"High","gaps":["Did not address redundancy with TAB3 in this context"]},{"year":2003,"claim":"Knockout mice revealed TAB2 is dispensable for IL-1 signaling in fibroblasts but essential for fetal liver survival, separating signaling redundancy from an anti-apoptotic role.","evidence":"TAB2 knockout mouse with embryonic phenotyping and MEF signaling assays","pmids":["12556483"],"confidence":"High","gaps":["Mechanism of the anti-apoptotic liver function not defined","Redundant factor compensating in MEFs not yet identified"]},{"year":2003,"claim":"Identified TAB3 as a functionally redundant paralog, explaining why single TAB2 loss is tolerated and that both are ubiquitinated via TRAF6.","evidence":"siRNA double knockdown, co-IP, and ubiquitination assays","pmids":["14633987"],"confidence":"High","gaps":["Did not establish the linkage type of TAB2/TAB3 ubiquitination","Functional consequence of TAB2 ubiquitination unclear"]},{"year":2004,"claim":"Defined the mechanistic core: the NZF zinc finger binds K63-linked polyubiquitin and this binding is necessary and sufficient (via domain swap) for TAK1/IKK activation.","evidence":"In vitro ubiquitin binding, mutagenesis, and heterologous domain-swap rescue with co-IP","pmids":["15327770"],"confidence":"High","gaps":["Structural basis of K63 selectivity not yet resolved","Physiological ubiquitinated targets only partly defined (RIP)"]},{"year":2005,"claim":"Genetic dissection placed TAK1 as essential and TAB2/TAB1 as individually dispensable across TNFR1/IL-1R/TLR signaling, clarifying the division of labor in the complex.","evidence":"Conditional knockout MEFs with NF-κB/AP-1 reporter and kinase assays","pmids":["16260493"],"confidence":"High","gaps":["Did not test combined TAB2/TAB3 loss","In vivo immune consequences not addressed"]},{"year":2006,"claim":"Mapped reciprocal binding interfaces between TAB2 (residues 574–693) and TAK1 (residues 479–553), enabling a disrupting peptide that blocks signaling and osteoclast differentiation.","evidence":"Deletion mapping, co-IP, dominant-negative peptide, and osteoclast differentiation assays","pmids":["17158449"],"confidence":"High","gaps":["Did not provide atomic structure of the interface"]},{"year":2009,"claim":"Crystal structures explained K63 selectivity by showing two-site recognition of adjacent ubiquitins via the Ile44 patch with conformational constraints incompatible with linear chains.","evidence":"X-ray crystallography of NZF–K63 di/triubiquitin complexes with mutagenesis","pmids":["19935683","19927120"],"confidence":"High","gaps":["Did not address binding to other non-K63 linkages such as K6"]},{"year":2009,"claim":"Revealed a non-inflammatory scaffolding role, recruiting calcineurin/RCAN1 to TAK1 so that TAK1 phosphorylates RCAN1 to facilitate calcineurin-NFAT signaling.","evidence":"Yeast two-hybrid, in vitro kinase reconstitution, mutagenesis, and Tab2-deficient MEFs","pmids":["19136967"],"confidence":"High","gaps":["Physiological tissue context of this module not defined"]},{"year":2010,"claim":"Extended TAB2 scaffolding to Wnt repression by bridging TAK1 to NLK to drive LEF1 ubiquitylation and inhibit β-catenin signaling.","evidence":"Co-IP, domain mapping (residues 292–417), siRNA, and luciferase reporter","pmids":["20194509"],"confidence":"Medium","gaps":["Single lab","In vivo relevance to Wnt-dependent processes not tested"]},{"year":2011,"claim":"Identified a TAB2/TAB3-Beclin 1 interaction that restrains autophagy, with a switch in which TAB2/TAB3 dissociate from Beclin 1 to engage TAK1 upon autophagy induction.","evidence":"Co-IP, coiled-coil domain mapping, siRNA/overexpression with autophagy readouts","pmids":["22081109"],"confidence":"High","gaps":["Trigger that releases TAB2 from Beclin 1 not defined","Direct effect on Beclin 1 function unresolved"]},{"year":2008,"claim":"Established degradative regulation of TAB2 by demonstrating TRIM30α-mediated degradation in an NF-κB-dependent negative-feedback loop.","evidence":"Co-IP, degradation assay, siRNA, and transgenic mouse with NF-κB reporter","pmids":["18345001"],"confidence":"High","gaps":["Ubiquitin linkage on TAB2 not specified","Degradation route (proteasome vs lysosome) not defined here"]},{"year":2014,"claim":"Distinguished lysosomal from proteasomal turnover, showing TRIM38 drives ligase-activity-independent lysosomal degradation of TAB2 to dampen TAK1 activation.","evidence":"Co-IP, lysosomal inhibitor assay, TRIM38 knockout cells, and RING-domain mutant","pmids":["24434549"],"confidence":"High","gaps":["Trafficking machinery routing TAB2 to lysosomes not defined"]},{"year":2023,"claim":"Defined site-specific proteasomal control via RNF99-mediated K48 ubiquitination of TAB2 at Lys611 with an in vivo TLR hyperresponsiveness phenotype.","evidence":"Co-IP, K48-ubiquitination assay, K611 mutagenesis, and RNF99 knockout mouse","pmids":["36681779"],"confidence":"High","gaps":["Stimulus controlling RNF99 engagement of TAB2 not defined"]},{"year":2020,"claim":"Identified deubiquitinase counter-regulation, showing USP15 (K48 removal plus a DUB-independent block of lysosomal degradation) and later USP25 (K63 removal) tune TAB2 stability and signaling output.","evidence":"Deubiquitination assays, co-IP, lysosomal inhibitor assays, and NF-κB reporter; USP25 with in vivo AAV9 knockdown","pmids":["31903660","37587766"],"confidence":"Medium","gaps":["Single lab per DUB","Interplay between opposing E3/DUB activities not reconstituted"]},{"year":2017,"claim":"Quantified the contribution of K63-ubiquitin binding to signaling duration, showing TAB2/TAB3 are needed for sustained (not initial) TAK1 activation and that the binding-defective mutant fails to rescue triple-knockout cells.","evidence":"TAB2/TAB3 double- and TAB1/2/3 triple-knockout cells with ubiquitin-binding mutant reconstitution and kinase assays","pmids":["28507161"],"confidence":"High","gaps":["Mechanism converting ubiquitin binding into sustained kinase output not fully defined"]},{"year":2022,"claim":"Revealed a cardioprotective cell-death function in which TAB2 mediates TAK1-dependent RIPK1 Ser321 phosphorylation to suppress apoptosis and necroptosis, with loss causing dilated cardiomyopathy.","evidence":"Cardiomyocyte-specific knockout, RIPK1 phosphorylation assay, RIPK1-K45A knockin rescue, and death-complex IP","pmids":["34990405"],"confidence":"High","gaps":["Whether TAB2's ubiquitin binding is required for RIPK1 regulation not isolated","Generality beyond cardiomyocytes untested"]},{"year":2024,"claim":"Resolved earlier conflicting redundancy data with an improved double-knockout model, confirming TAB2/TAB3 are redundantly required for TLR-driven NF-κB/MAPK activation, IκBζ expression, and IL-6 production in macrophages.","evidence":"TAB2/TAB3 double-knockout macrophages with cytokine and signaling assays and IκBζ analysis","pmids":["38567483"],"confidence":"High","gaps":["Mechanism by which TAB2/TAB3 control IκBζ transcription not defined"]},{"year":null,"claim":"How the diverse non-canonical TAB2 functions (calcineurin-NFAT, NLK-Wnt, Beclin 1-autophagy, RIPK1 cell death, ERα corepressor dismissal) are coordinated with its canonical ubiquitin-dependent TAK1 scaffolding, and which require NZF ubiquitin binding, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying model linking ubiquitin binding to the non-TAK1 functions","Tissue- and stimulus-specific partitioning of TAB2 functions not mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,7,19,20]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,2]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,2]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,3,4,37]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,7,31]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[21]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[34]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[15,24,36]}],"complexes":["TAK1-TAB1-TAB2 kinase complex","TRAF6-TAK1-TAB1-TAB2 complex"],"partners":["TAK1","TAB1","TRAF6","NLK","BECN1","RIPK1","RCAN1","TRAF2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9NYJ8","full_name":"TGF-beta-activated kinase 1 and MAP3K7-binding protein 2","aliases":["Mitogen-activated protein kinase kinase kinase 7-interacting protein 2","TAK1-binding protein 2","TAB-2","TGF-beta-activated kinase 1-binding protein 2"],"length_aa":693,"mass_kda":76.5,"function":"Adapter required to activate the JNK and NF-kappa-B signaling pathways through the specific recognition of 'Lys-63'-linked polyubiquitin chains by its RanBP2-type zinc finger (NZF) (PubMed:10882101, PubMed:11460167, PubMed:15327770, PubMed:22158122, PubMed:27746020, PubMed:33184450, PubMed:36681779). Acts as an adapter linking MAP3K7/TAK1 and TRAF6 to 'Lys-63'-linked polyubiquitin chains (PubMed:10882101, PubMed:11460167, PubMed:15327770, PubMed:22158122, PubMed:27746020). The RanBP2-type zinc finger (NZF) specifically recognizes Lys-63'-linked polyubiquitin chains unanchored or anchored to the substrate proteins such as RIPK1/RIP1 and RIPK2: this acts as a scaffold to organize a large signaling complex to promote autophosphorylation of MAP3K7/TAK1, and subsequent activation of I-kappa-B-kinase (IKK) core complex by MAP3K7/TAK1 (PubMed:15327770, PubMed:18079694, PubMed:22158122). Also recognizes and binds Lys-63'-linked polyubiquitin chains of heterotypic 'Lys-63'-/'Lys-48'-linked branched ubiquitin chains (PubMed:27746020). Regulates the IL1-mediated translocation of NCOR1 out of the nucleus (By similarity). Involved in heart development (PubMed:20493459)","subcellular_location":"Membrane; Endosome membrane; Lysosome membrane; Cytoplasm, cytosol","url":"https://www.uniprot.org/uniprotkb/Q9NYJ8/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TAB2","classification":"Not Classified","n_dependent_lines":13,"n_total_lines":1208,"dependency_fraction":0.01076158940397351},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"MAP3K7","stoichiometry":10.0},{"gene":"ANKRD10","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/TAB2","total_profiled":1310},"omim":[{"mim_id":"617920","title":"AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 3; PLCA3","url":"https://www.omim.org/entry/617920"},{"mim_id":"617137","title":"FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2","url":"https://www.omim.org/entry/617137"},{"mim_id":"615657","title":"MICRO RNA 142; MIR142","url":"https://www.omim.org/entry/615657"},{"mim_id":"614980","title":"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2; CHTD2","url":"https://www.omim.org/entry/614980"},{"mim_id":"613363","title":"DYNEIN, CYTOPLASMIC 2, INTERMEDIATE CHAIN 2; DYNC2I2","url":"https://www.omim.org/entry/613363"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TAB2"},"hgnc":{"alias_symbol":["KIAA0733"],"prev_symbol":["MAP3K7IP2"]},"alphafold":{"accession":"Q9NYJ8","domains":[{"cath_id":"1.20.5","chopping":"525-583","consensus_level":"medium","plddt":91.6459,"start":525,"end":583}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NYJ8","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NYJ8-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NYJ8-F1-predicted_aligned_error_v6.png","plddt_mean":52.41},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TAB2","jax_strain_url":"https://www.jax.org/strain/search?query=TAB2"},"sequence":{"accession":"Q9NYJ8","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NYJ8.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NYJ8/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NYJ8"}},"corpus_meta":[{"pmid":"15327770","id":"PMC_15327770","title":"TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains.","date":"2004","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/15327770","citation_count":749,"is_preprint":false},{"pmid":"16260493","id":"PMC_16260493","title":"TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo.","date":"2005","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/16260493","citation_count":622,"is_preprint":false},{"pmid":"10882101","id":"PMC_10882101","title":"TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway.","date":"2000","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/10882101","citation_count":515,"is_preprint":false},{"pmid":"22660635","id":"PMC_22660635","title":"The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α.","date":"2012","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22660635","citation_count":372,"is_preprint":false},{"pmid":"12609980","id":"PMC_12609980","title":"Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFkappa B and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR .","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12609980","citation_count":245,"is_preprint":false},{"pmid":"14633987","id":"PMC_14633987","title":"Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling.","date":"2003","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/14633987","citation_count":239,"is_preprint":false},{"pmid":"11809792","id":"PMC_11809792","title":"Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11809792","citation_count":236,"is_preprint":false},{"pmid":"12242293","id":"PMC_12242293","title":"Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12242293","citation_count":233,"is_preprint":false},{"pmid":"18345001","id":"PMC_18345001","title":"TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation.","date":"2008","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18345001","citation_count":215,"is_preprint":false},{"pmid":"15590691","id":"PMC_15590691","title":"Critical roles of threonine 187 phosphorylation in cellular stress-induced rapid and transient activation of transforming growth factor-beta-activated kinase 1 (TAK1) in a signaling complex containing TAK1-binding protein TAB1 and TAB2.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15590691","citation_count":186,"is_preprint":false},{"pmid":"19935683","id":"PMC_19935683","title":"Two-sided ubiquitin binding explains specificity of the TAB2 NZF domain.","date":"2009","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19935683","citation_count":180,"is_preprint":false},{"pmid":"11518704","id":"PMC_11518704","title":"IRAK-mediated translocation of TRAF6 and TAB2 in the interleukin-1-induced activation of NFkappa B.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11518704","citation_count":174,"is_preprint":false},{"pmid":"11259596","id":"PMC_11259596","title":"Interleukin-1 (IL-1) receptor-associated kinase leads to activation of TAK1 by inducing TAB2 translocation in the IL-1 signaling pathway.","date":"2001","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11259596","citation_count":161,"is_preprint":false},{"pmid":"24434549","id":"PMC_24434549","title":"TRIM38 inhibits TNFα- and IL-1β-triggered NF-κB activation by mediating lysosome-dependent degradation of TAB2/3.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24434549","citation_count":125,"is_preprint":false},{"pmid":"17384642","id":"PMC_17384642","title":"Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2.","date":"2007","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17384642","citation_count":123,"is_preprint":false},{"pmid":"19927120","id":"PMC_19927120","title":"Structural basis for specific recognition of Lys 63-linked polyubiquitin chains by NZF domains of TAB2 and TAB3.","date":"2009","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/19927120","citation_count":121,"is_preprint":false},{"pmid":"17158449","id":"PMC_17158449","title":"TAK1-dependent signaling requires functional interaction with TAB2/TAB3.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17158449","citation_count":120,"is_preprint":false},{"pmid":"19136967","id":"PMC_19136967","title":"Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin defines a signalling nodal control point.","date":"2009","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19136967","citation_count":113,"is_preprint":false},{"pmid":"12556483","id":"PMC_12556483","title":"TAB2 is essential for prevention of apoptosis in fetal liver but not for interleukin-1 signaling.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12556483","citation_count":109,"is_preprint":false},{"pmid":"20493459","id":"PMC_20493459","title":"Haploinsufficiency of TAB2 causes congenital heart defects in humans.","date":"2010","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20493459","citation_count":88,"is_preprint":false},{"pmid":"24942571","id":"PMC_24942571","title":"Enterovirus 71 3C inhibits cytokine expression through cleavage of the TAK1/TAB1/TAB2/TAB3 complex.","date":"2014","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/24942571","citation_count":86,"is_preprint":false},{"pmid":"16251197","id":"PMC_16251197","title":"TAB2, TRAF6 and TAK1 are involved in NF-kappaB activation induced by the TNF-receptor, Edar and its adaptator Edaradd.","date":"2005","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16251197","citation_count":85,"is_preprint":false},{"pmid":"22081109","id":"PMC_22081109","title":"Inhibition of autophagy by TAB2 and TAB3.","date":"2011","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/22081109","citation_count":84,"is_preprint":false},{"pmid":"16384851","id":"PMC_16384851","title":"Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves' disease.","date":"2005","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/16384851","citation_count":78,"is_preprint":false},{"pmid":"17449468","id":"PMC_17449468","title":"RBCK1 negatively regulates tumor necrosis factor- and interleukin-1-triggered NF-kappaB activation by targeting TAB2/3 for degradation.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17449468","citation_count":66,"is_preprint":false},{"pmid":"31903660","id":"PMC_31903660","title":"USP15 potentiates NF-κB activation by differentially stabilizing TAB2 and TAB3.","date":"2020","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/31903660","citation_count":60,"is_preprint":false},{"pmid":"20948191","id":"PMC_20948191","title":"IFN-γ and TNF-α synergistically induce microRNA-155 which regulates TAB2/IP-10 expression in human mesangial cells.","date":"2010","source":"American journal of nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/20948191","citation_count":54,"is_preprint":false},{"pmid":"16079232","id":"PMC_16079232","title":"A genetic screen targeting the tumor necrosis factor/Eiger signaling pathway: identification of Drosophila TAB2 as a functionally conserved component.","date":"2005","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16079232","citation_count":54,"is_preprint":false},{"pmid":"36990276","id":"PMC_36990276","title":"MicroRNAs of extracellular vesicles derived from mesenchymal stromal cells alleviate inflammation in dry eye disease by targeting the IRAK1/TAB2/NF-κB pathway.","date":"2023","source":"The ocular surface","url":"https://pubmed.ncbi.nlm.nih.gov/36990276","citation_count":53,"is_preprint":false},{"pmid":"23509369","id":"PMC_23509369","title":"Essential roles of K63-linked polyubiquitin-binding proteins TAB2 and TAB3 in B cell activation via MAPKs.","date":"2013","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/23509369","citation_count":52,"is_preprint":false},{"pmid":"16311020","id":"PMC_16311020","title":"Drosophila TAB2 is required for the immune activation of JNK and NF-kappaB.","date":"2005","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/16311020","citation_count":49,"is_preprint":false},{"pmid":"15220215","id":"PMC_15220215","title":"A 212-kb region on chromosome 6q25 containing the TAB2 gene is associated with susceptibility to type 1 diabetes.","date":"2004","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/15220215","citation_count":44,"is_preprint":false},{"pmid":"30760523","id":"PMC_30760523","title":"G protein-coupled receptors activate p38 MAPK via a non-canonical TAB1-TAB2- and TAB1-TAB3-dependent pathway in endothelial cells.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30760523","citation_count":42,"is_preprint":false},{"pmid":"29753717","id":"PMC_29753717","title":"TRIM38 regulates NF-κB activation through TAB2 degradation in osteoclast and osteoblast differentiation.","date":"2018","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/29753717","citation_count":42,"is_preprint":false},{"pmid":"23818111","id":"PMC_23818111","title":"TRIM22 inhibits the TRAF6-stimulated NF-κB pathway by targeting TAB2 for degradation.","date":"2013","source":"Virologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/23818111","citation_count":42,"is_preprint":false},{"pmid":"34990405","id":"PMC_34990405","title":"TAB2 deficiency induces dilated cardiomyopathy by promoting RIPK1-dependent apoptosis and necroptosis.","date":"2022","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/34990405","citation_count":40,"is_preprint":false},{"pmid":"37587766","id":"PMC_37587766","title":"USP25 Inhibits Neuroinflammatory Responses After Cerebral Ischemic Stroke by Deubiquitinating TAB2.","date":"2023","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/37587766","citation_count":38,"is_preprint":false},{"pmid":"28507161","id":"PMC_28507161","title":"Interleukin-1 and TRAF6-dependent activation of TAK1 in the absence of TAB2 and TAB3.","date":"2017","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/28507161","citation_count":37,"is_preprint":false},{"pmid":"21700681","id":"PMC_21700681","title":"TAK1-TAB2 signaling contributes to bone destruction by breast carcinoma cells.","date":"2011","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/21700681","citation_count":36,"is_preprint":false},{"pmid":"15729364","id":"PMC_15729364","title":"Functional variants in SUMO4, TAB2, and NFkappaB and the risk of type 1 diabetes.","date":"2005","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/15729364","citation_count":35,"is_preprint":false},{"pmid":"28295271","id":"PMC_28295271","title":"NLRP6 facilitates the interaction between TAB2/3 and TRIM38 in rheumatoid arthritis fibroblast-like synoviocytes.","date":"2017","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/28295271","citation_count":33,"is_preprint":false},{"pmid":"20194509","id":"PMC_20194509","title":"TAB2 scaffolds TAK1 and NLK in repressing canonical Wnt signaling.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20194509","citation_count":30,"is_preprint":false},{"pmid":"32810129","id":"PMC_32810129","title":"Drosophila Myc restores immune homeostasis of Imd pathway via activating miR-277 to inhibit imd/Tab2.","date":"2020","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32810129","citation_count":30,"is_preprint":false},{"pmid":"22249258","id":"PMC_22249258","title":"Targeting of the adaptor protein Tab2 as a novel approach to revert tamoxifen resistance in breast cancer cells.","date":"2012","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/22249258","citation_count":29,"is_preprint":false},{"pmid":"17626013","id":"PMC_17626013","title":"Constitutive activation of TAK1 by HTLV-1 tax-dependent overexpression of TAB2 induces activation of JNK-ATF2 but not IKK-NF-kappaB.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17626013","citation_count":29,"is_preprint":false},{"pmid":"26102459","id":"PMC_26102459","title":"Identification and functional characterization of the TAB2 gene from Litopenaeus vannamei.","date":"2015","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26102459","citation_count":27,"is_preprint":false},{"pmid":"17986383","id":"PMC_17986383","title":"HTLV-1 Tax-mediated TAK1 activation involves TAB2 adapter protein.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17986383","citation_count":27,"is_preprint":false},{"pmid":"33535081","id":"PMC_33535081","title":"Circ_AFF2 facilitates proliferation and inflammatory response of fibroblast-like synoviocytes in rheumatoid arthritis via the miR-375/TAB2 axis.","date":"2021","source":"Experimental and molecular pathology","url":"https://pubmed.ncbi.nlm.nih.gov/33535081","citation_count":27,"is_preprint":false},{"pmid":"34456334","id":"PMC_34456334","title":"TAB2 deletions and variants cause a highly recognisable syndrome with mitral valve disease, cardiomyopathy, short stature and hypermobility.","date":"2021","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/34456334","citation_count":26,"is_preprint":false},{"pmid":"18299187","id":"PMC_18299187","title":"NUMBL interacts with TAB2 and inhibits TNFalpha and IL-1beta-induced NF-kappaB activation.","date":"2008","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/18299187","citation_count":26,"is_preprint":false},{"pmid":"26875893","id":"PMC_26875893","title":"Interleukin-17A inhibits cell autophagy under starvation and promotes cell migration via TAB2/TAB3-p38 mitogen-activated protein kinase pathways in hepatocellular carcinoma.","date":"2016","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26875893","citation_count":26,"is_preprint":false},{"pmid":"22167179","id":"PMC_22167179","title":"Reciprocal inhibition between the transforming growth factor-β-activated kinase 1 (TAK1) and apoptosis signal-regulating kinase 1 (ASK1) mitogen-activated protein kinase kinase kinases and its suppression by TAK1-binding protein 2 (TAB2), an adapter protein for TAK1.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22167179","citation_count":26,"is_preprint":false},{"pmid":"28464518","id":"PMC_28464518","title":"6q25.1 (TAB2) microdeletion syndrome: Congenital heart defects and cardiomyopathy.","date":"2017","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/28464518","citation_count":25,"is_preprint":false},{"pmid":"26299341","id":"PMC_26299341","title":"RNF4 negatively regulates NF-κB signaling by down-regulating TAB2.","date":"2015","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/26299341","citation_count":25,"is_preprint":false},{"pmid":"26432169","id":"PMC_26432169","title":"Phosphoinositide-dependent kinase-1 inhibits TRAF6 ubiquitination by interrupting the formation of TAK1-TAB2 complex in TLR4 signaling.","date":"2015","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/26432169","citation_count":24,"is_preprint":false},{"pmid":"31494298","id":"PMC_31494298","title":"MiR-142a-3p alleviates Escherichia coli derived lipopolysaccharide-induced acute lung injury by targeting TAB2.","date":"2019","source":"Microbial pathogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/31494298","citation_count":24,"is_preprint":false},{"pmid":"35081354","id":"PMC_35081354","title":"Selective autophagy controls innate immune response through a TAK1/TAB2/SH3PX1 axis.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/35081354","citation_count":23,"is_preprint":false},{"pmid":"33111257","id":"PMC_33111257","title":"Antagonism of Protease-Activated Receptor 4 Protects Against Traumatic Brain Injury by Suppressing Neuroinflammation via Inhibition of Tab2/NF-κB Signaling.","date":"2020","source":"Neuroscience bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/33111257","citation_count":23,"is_preprint":false},{"pmid":"33717111","id":"PMC_33717111","title":"Hepatitis B Surface Antigen Suppresses the Activation of Nuclear Factor Kappa B Pathway via Interaction With the TAK1-TAB2 Complex.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33717111","citation_count":22,"is_preprint":false},{"pmid":"34331613","id":"PMC_34331613","title":"microRNA-149-5p mediates the PM2.5-induced inflammatory response by targeting TAB2 via MAPK and NF-κB signaling pathways in vivo and in vitro.","date":"2021","source":"Cell biology and toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/34331613","citation_count":21,"is_preprint":false},{"pmid":"28386937","id":"PMC_28386937","title":"A recognizable systemic connective tissue disorder with polyvalvular heart dystrophy and dysmorphism associated with TAB2 mutations.","date":"2017","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28386937","citation_count":21,"is_preprint":false},{"pmid":"29700987","id":"PMC_29700987","title":"Protein molecular modeling techniques investigating novel TAB2 variant R347X causing cardiomyopathy and congenital heart defects in multigenerational family.","date":"2018","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29700987","citation_count":20,"is_preprint":false},{"pmid":"26577385","id":"PMC_26577385","title":"Docosahexaenoic acid inhibits inflammation via free fatty acid receptor FFA4, disruption of TAB2 interaction with TAK1/TAB1 and downregulation of ERK-dependent Egr-1 expression in EA.hy926 cells.","date":"2015","source":"Molecular nutrition & food research","url":"https://pubmed.ncbi.nlm.nih.gov/26577385","citation_count":20,"is_preprint":false},{"pmid":"34551195","id":"PMC_34551195","title":"Circular RNA WHSC1 exerts oncogenic properties by regulating miR-7/TAB2 in lung cancer.","date":"2021","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34551195","citation_count":19,"is_preprint":false},{"pmid":"31997570","id":"PMC_31997570","title":"Stabilization of the TAK1 adaptor proteins TAB2 and TAB3 is critical for optimal NF-κB activation.","date":"2020","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/31997570","citation_count":19,"is_preprint":false},{"pmid":"35982795","id":"PMC_35982795","title":"Tripartite motif 38 attenuates cardiac fibrosis after myocardial infarction by suppressing TAK1 activation via TAB2/3 degradation.","date":"2022","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/35982795","citation_count":19,"is_preprint":false},{"pmid":"31959127","id":"PMC_31959127","title":"A novel TAB2 nonsense mutation (p.S149X) causing autosomal dominant congenital heart defects: a case report of a Chinese family.","date":"2020","source":"BMC cardiovascular disorders","url":"https://pubmed.ncbi.nlm.nih.gov/31959127","citation_count":19,"is_preprint":false},{"pmid":"36681779","id":"PMC_36681779","title":"E3 ligase RNF99 negatively regulates TLR-mediated inflammatory immune response via K48-linked ubiquitination of TAB2.","date":"2023","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/36681779","citation_count":18,"is_preprint":false},{"pmid":"33174006","id":"PMC_33174006","title":"lncRNA CASC2 inhibits lipopolysaccharide‑induced acute lung injury via miR‑27b/TAB2 axis.","date":"2020","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/33174006","citation_count":18,"is_preprint":false},{"pmid":"38906869","id":"PMC_38906869","title":"Regulator of G protein signaling 16 restrains apoptosis in colorectal cancer through disrupting TRAF6-TAB2-TAK1-JNK/p38 MAPK signaling.","date":"2024","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/38906869","citation_count":18,"is_preprint":false},{"pmid":"24096733","id":"PMC_24096733","title":"TAB2, an important upstream adaptor of interleukin-1 signaling pathway, is subject to SUMOylation.","date":"2013","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24096733","citation_count":17,"is_preprint":false},{"pmid":"27452334","id":"PMC_27452334","title":"Whole Exome Sequencing, Familial Genomic Triangulation, and Systems Biology Converge to Identify a Novel Nonsense Mutation in TAB2-encoded TGF-beta Activated Kinase 1 in a Child with Polyvalvular Syndrome.","date":"2016","source":"Congenital heart disease","url":"https://pubmed.ncbi.nlm.nih.gov/27452334","citation_count":17,"is_preprint":false},{"pmid":"36332385","id":"PMC_36332385","title":"Inhibition of TAK1/TAB2 complex formation by costunolide attenuates obesity cardiomyopathy via the NF-κB signaling pathway.","date":"2022","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36332385","citation_count":16,"is_preprint":false},{"pmid":"34554275","id":"PMC_34554275","title":"gga-miR-142-3p negatively regulates Mycoplasma gallisepticum (HS strain)-induced inflammatory cytokine production via the NF-κB and MAPK signaling by targeting TAB2.","date":"2021","source":"Inflammation research : official journal of the European Histamine Research Society ... [et al.]","url":"https://pubmed.ncbi.nlm.nih.gov/34554275","citation_count":15,"is_preprint":false},{"pmid":"37116711","id":"PMC_37116711","title":"Tripartite motif 38 alleviates the pathological process of NAFLD-NASH by promoting TAB2 degradation.","date":"2023","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/37116711","citation_count":14,"is_preprint":false},{"pmid":"24747054","id":"PMC_24747054","title":"TAK1-binding proteins (TAB1 and TAB2) in grass carp (Ctenopharyngodon idella): identification, characterization, and expression analysis after infection with Ichthyophthirius multifiliis.","date":"2014","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24747054","citation_count":12,"is_preprint":false},{"pmid":"32183715","id":"PMC_32183715","title":"6q25.1 (TAB2) microdeletion is a risk factor for hypoplastic left heart: a case report that expands the phenotype.","date":"2020","source":"BMC cardiovascular disorders","url":"https://pubmed.ncbi.nlm.nih.gov/32183715","citation_count":12,"is_preprint":false},{"pmid":"31981616","id":"PMC_31981616","title":"A single nucleotide deletion resulting in a frameshift in exon 4 of TAB2 is associated with a polyvalular syndrome.","date":"2020","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31981616","citation_count":12,"is_preprint":false},{"pmid":"21918865","id":"PMC_21918865","title":"Rhesus monkey TRIM5α represses HIV-1 LTR promoter activity by negatively regulating TAK1/TAB1/TAB2/TAB3-complex-mediated NF-κB activation.","date":"2011","source":"Archives of virology","url":"https://pubmed.ncbi.nlm.nih.gov/21918865","citation_count":12,"is_preprint":false},{"pmid":"35971781","id":"PMC_35971781","title":"Expanding the phenotype of TAB2 variants and literature review.","date":"2022","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/35971781","citation_count":10,"is_preprint":false},{"pmid":"33347907","id":"PMC_33347907","title":"microRNA-128 inhibits the inflammatory responses by targeting TAB2 in miiuy croaker, Miichthysmiiuy.","date":"2020","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33347907","citation_count":10,"is_preprint":false},{"pmid":"27497262","id":"PMC_27497262","title":"TAK1 adaptor proteins, TAB2 and TAB3, link the signalosome to B-cell receptor-induced IKK activation.","date":"2016","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/27497262","citation_count":8,"is_preprint":false},{"pmid":"17406806","id":"PMC_17406806","title":"Expression analysis of the TAB2 protein in adult mouse tissues.","date":"2007","source":"Inflammation research : official journal of the European Histamine Research Society ... [et al.]","url":"https://pubmed.ncbi.nlm.nih.gov/17406806","citation_count":7,"is_preprint":false},{"pmid":"34306095","id":"PMC_34306095","title":"TAB2 Promotes the Stemness and Biological Functions of Cervical Squamous Cell Carcinoma Cells.","date":"2021","source":"Stem cells international","url":"https://pubmed.ncbi.nlm.nih.gov/34306095","citation_count":7,"is_preprint":false},{"pmid":"27992601","id":"PMC_27992601","title":"A Novel Functional Domain of Tab2 Involved in the Interaction with Estrogen Receptor Alpha in Breast Cancer Cells.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27992601","citation_count":7,"is_preprint":false},{"pmid":"31250519","id":"PMC_31250519","title":"TAB2 c.1398dup variant leads to haploinsufficiency and impairs extracellular matrix homeostasis.","date":"2019","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/31250519","citation_count":6,"is_preprint":false},{"pmid":"34242591","id":"PMC_34242591","title":"Structural basis for specific recognition of K6-linked polyubiquitin chains by the TAB2 NZF domain.","date":"2021","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/34242591","citation_count":6,"is_preprint":false},{"pmid":"38567483","id":"PMC_38567483","title":"TAK1-binding protein 2 (TAB2) and TAB3 are redundantly required for TLR-induced cytokine production in macrophages.","date":"2024","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/38567483","citation_count":5,"is_preprint":false},{"pmid":"32270697","id":"PMC_32270697","title":"Associations between TAB2 gene polymorphisms and dilated cardiomyopathy in a Chinese population.","date":"2020","source":"Biomarkers in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32270697","citation_count":5,"is_preprint":false},{"pmid":"31485280","id":"PMC_31485280","title":"Associations between TAB2 Gene Polymorphisms and Epithelial Ovarian Cancer in a Chinese Population.","date":"2019","source":"Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/31485280","citation_count":5,"is_preprint":false},{"pmid":"35865515","id":"PMC_35865515","title":"A Novel MicroRNA and the Target Gene TAB2 Can Regulate the Process of Sucking Blood in and the Spawn Rate of Hyalomma asiaticum (Acari: Ixodidae) Ticks.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35865515","citation_count":5,"is_preprint":false},{"pmid":"32823238","id":"PMC_32823238","title":"TET2 promotes IL-1β expression in J774.1 cell through TLR4/MAPK signaling pathway with demethylation of TAB2 promoter.","date":"2020","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32823238","citation_count":5,"is_preprint":false},{"pmid":"16879932","id":"PMC_16879932","title":"Tab2, a novel recombinant polypeptide tag offering sensitive and specific protein detection and reliable affinity purification.","date":"2006","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/16879932","citation_count":5,"is_preprint":false},{"pmid":"39693936","id":"PMC_39693936","title":"Long non-coding RNA OIP5-AS1 protects neurons from ischemia-reperfusion injury and inhibits neuronal apoptosis through TAB-2.","date":"2024","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/39693936","citation_count":5,"is_preprint":false},{"pmid":"35978886","id":"PMC_35978886","title":"TAB2 Promotes the Biological Functions of Head and Neck Squamous Cell Carcinoma Cells via EMT and PI3K Pathway.","date":"2022","source":"Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/35978886","citation_count":4,"is_preprint":false},{"pmid":"37153890","id":"PMC_37153890","title":"Growth restriction and congenital heart disease caused by a novel TAB2 mutation: A case report.","date":"2023","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37153890","citation_count":4,"is_preprint":false},{"pmid":"16755651","id":"PMC_16755651","title":"SUMO4 and MAP3K7IP2 single nucleotide polymorphisms and susceptibility to rheumatoid arthritis.","date":"2006","source":"The Journal of rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/16755651","citation_count":3,"is_preprint":false},{"pmid":"39358475","id":"PMC_39358475","title":"The antisense lncRNA of TAB2 that prevents oxidative stress to enhance the follicular growth in mammals.","date":"2024","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/39358475","citation_count":3,"is_preprint":false},{"pmid":"40852992","id":"PMC_40852992","title":"Lumpy skin disease virus LSDV001 protein positively regulates inflammatory response by promoting assembly of the TAK1-TAB2/3 complex.","date":"2025","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/40852992","citation_count":3,"is_preprint":false},{"pmid":"34716296","id":"PMC_34716296","title":"A novel TAB2 mutation detected in a putative case of frontometaphyseal dysplasia.","date":"2021","source":"Human genome variation","url":"https://pubmed.ncbi.nlm.nih.gov/34716296","citation_count":3,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50743,"output_tokens":9916,"usd":0.150484,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20241,"output_tokens":5740,"usd":0.122353,"stage2_stop_reason":"end_turn"},"total_usd":0.272837,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"TAB2 is an adaptor protein that physically links TAK1 to TRAF6 in the IL-1 signaling pathway. IL-1 stimulation induces translocation of TAB2 from the membrane to the cytosol, where it mediates IL-1-dependent association of TAK1 with TRAF6, leading to TAK1 activation and downstream JNK and NF-κB activation. Dominant-negative TAB2 impairs JNK and NF-κB activation by IL-1.\",\n      \"method\": \"Co-immunoprecipitation, dominant-negative overexpression, subcellular fractionation\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, dominant-negative functional rescue, subcellular localization with functional consequence; foundational paper replicated extensively\",\n      \"pmids\": [\"10882101\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"IRAK is required for IL-1-induced TAB2 translocation from the membrane to the cytosol. In IRAK-deficient cells, TAB2 translocation and its association with TRAF6 are abolished, preventing formation of the TRAF6-TAB2-TAK1 complex and TAK1 activation.\",\n      \"method\": \"IRAK-deficient cell lines, subcellular fractionation, co-immunoprecipitation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function (IRAK-deficient cells), co-IP, localization assay with defined phenotype; replicated by independent lab (PMID:11518704)\",\n      \"pmids\": [\"11259596\", \"11518704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"In IL-1 signaling, IRAK recruits TRAF6 to a membrane complex (complex I), which then associates with pre-formed TAK1-TAB1-TAB2 on the membrane (complex II). This leads to phosphorylation of TAK1 and TAB2 on the membrane, followed by dissociation of the TRAF6-TAK1-TAB1-TAB2 complex (complex III) and translocation to the cytosol where TAK1 is activated.\",\n      \"method\": \"Sequential co-immunoprecipitation, subcellular fractionation, phosphorylation assays with IRAK-deficient cells\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal biochemical methods, genetic loss-of-function, clear mechanistic dissection of complex assembly/disassembly\",\n      \"pmids\": [\"12242293\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"TAK1 and TAB2 participate in the RANK signaling pathway. RANKL stimulation promotes formation of a complex containing RANK, TRAF6, TAB2, and TAK1, leading to TAK1 activation. Dominant-negative TAB2 inhibits NF-κB activation induced by RANK overexpression and by RANKL in monocyte RAW264.7 cells.\",\n      \"method\": \"Co-immunoprecipitation in RANK-stably transfected 293 cells, dominant-negative overexpression, kinase assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP, dominant-negative functional assay, two cell-line systems\",\n      \"pmids\": [\"11809792\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"TLR3-mediated NF-κB and MAP kinase activation proceeds through an IRAK-independent pathway in which TRAF6, TAK1, and TAB2 are recruited to the TLR3 receptor to form a complex that translocates to the cytosol where TAK1 is phosphorylated and activated. PKR is also detected in this TAK1 complex.\",\n      \"method\": \"IRAK-deficient cell lines, co-immunoprecipitation, subcellular fractionation, dominant-negative kinase assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function lines, co-IP, biochemical fractionation with two orthogonal functional readouts\",\n      \"pmids\": [\"12609980\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"TAB2-deficient mouse embryonic fibroblasts do not show impaired IL-1-induced NF-κB or MAP kinase activation, demonstrating that TAB2 alone is not essential for IL-1 signaling in fibroblasts. However, TAB2 knockout is embryonic lethal due to liver degeneration and apoptosis, indicating an essential anti-apoptotic role in fetal liver.\",\n      \"method\": \"TAB2 knockout mouse generation, embryonic fibroblast NF-κB activation assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knockout mouse with specific phenotypic readout, replicated by independent group (PMID:16260493)\",\n      \"pmids\": [\"12556483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"TAB3, a TAB2-like molecule, associates with TAK1 and activates NF-κB. Endogenous TAB3 interacts with TRAF6 and TRAF2 in an IL-1- and TNF-dependent manner, respectively. IL-1 signaling leads to ubiquitination of TAB2 and TAB3 through TRAF6. siRNA knockdown of both TAB2 and TAB3 (but not either alone) inhibits IL-1- and TNF-induced TAK1 and NF-κB activation, showing functional redundancy.\",\n      \"method\": \"siRNA double knockdown, co-immunoprecipitation, ubiquitination assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — siRNA knockdown with specific signaling readouts, co-IP, ubiquitination assay; establishes redundancy with TAB3\",\n      \"pmids\": [\"14633987\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"TAB2 and TAB3 bind preferentially to lysine 63-linked polyubiquitin chains through a conserved C-terminal zinc finger (NZF/ZnF) domain. Mutations of the ZnF domain abolish polyubiquitin binding and the ability to activate TAK1 and IKK. Replacement of the ZnF domain with a heterologous ubiquitin-binding domain restores TAK1 and IKK activation. TAB2 binds to polyubiquitinated RIP following TNF-α stimulation.\",\n      \"method\": \"In vitro ubiquitin-binding assay, site-directed mutagenesis, domain swap experiments, co-immunoprecipitation\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro binding assay with mutagenesis, domain swap rescue experiment, co-IP; multiply replicated foundational mechanism paper\",\n      \"pmids\": [\"15327770\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"TAB2 is involved in the phosphorylation of TAK1 at Thr-187 in the activation loop during TNF-α stress. TAB1 and TAB2 regulate TAK1 Thr-187 phosphorylation differentially. TAB2 is part of the TAK1 signaling complex required for stress-induced rapid and transient TAK1 activation.\",\n      \"method\": \"Phospho-specific antibody, RNA interference, overexpression experiments, kinase assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phospho-specific antibody with RNAi and overexpression, single lab, two orthogonal methods\",\n      \"pmids\": [\"15590691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"TAK1 (but not TAB1 or TAB2 alone) is essential for TNFR1-, IL-1R-, TLR3-, and TLR4-mediated NF-κB and AP-1 activation in embryonic fibroblasts. Tab1(-/-) and Tab2(-/-) fibroblasts show normal NF-κB and AP-1 responses, confirming the redundant/dispensable roles of TAB1 and TAB2 in these contexts.\",\n      \"method\": \"Conditional knockout mouse embryonic fibroblasts, NF-κB luciferase assays, kinase assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic knockout with multiple signaling readouts across multiple receptor systems\",\n      \"pmids\": [\"16260493\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"TAB2, TRAF6, and TAK1 are components of the Edar/Edaradd NF-κB signaling pathway. TAB2 was identified as a binding partner of Edaradd by yeast two-hybrid; endogenous TAB2, TRAF6, and TAK1 co-immunoprecipitate with Edaradd. Dominant-negative TAB2, TRAF6, and TAK1 block NF-κB activation by Edaradd.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, dominant-negative functional assay\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid plus co-IP plus dominant-negative assay, single lab\",\n      \"pmids\": [\"16251197\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Drosophila TAB2 (dTAB2) links dTRAF1 to the JNKKK dTAK1, functioning as an adaptor in the TNF/Eiger-JNK pathway. Genetic epistasis and biochemical protein-protein interaction assays establish dTAB2 as an essential component of this conserved signaling module.\",\n      \"method\": \"Genetic screen, epistasis analysis, protein-protein interaction assay\",\n      \"journal\": \"Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis plus biochemical interaction assay in Drosophila ortholog, single lab\",\n      \"pmids\": [\"16079232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The TAB2/TAB3-binding domain in TAK1 maps to a non-contiguous region in the last C-terminal 100 residues (residues 479–553 are necessary and sufficient). Residues 574–693 of TAB2 interact with TAK1. A peptide (TAK1-C100) that disrupts TAB2/TAB3-TAK1 interaction abolishes TAK1 phosphorylation and IKK/MAPK activation by IL-1, TNF, and RANKL, and blocks RANKL-induced osteoclast differentiation.\",\n      \"method\": \"Deletion mapping, co-immunoprecipitation, dominant-negative peptide, kinase assays, osteoclast differentiation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic domain mapping with co-IP, dominant-negative functional assays across multiple stimuli, two orthogonal readouts\",\n      \"pmids\": [\"17158449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Smad7 binds directly to TAB2 and TAB3, competing with TAK1 binding and blocking recruitment of TAK1 to TRAF2 in the TNF signaling pathway. Smad7-TAB2/TAB3 complex formation suppresses TNF-induced NF-κB activation. Transgenic Smad7 in mouse skin disrupts endogenous TRAF2-TAK1-TAB2 complex formation.\",\n      \"method\": \"Co-immunoprecipitation, in vitro binding assay, transgenic mouse model, NF-κB reporter assays\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vitro binding, co-IP, transgenic in vivo confirmation; multiple orthogonal methods\",\n      \"pmids\": [\"17384642\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"HTLV-1 Tax physically interacts with TAB2; TAB2 and Tax cooperatively activate TAK1, and TAK1 activation by Tax requires TAB2 binding as well as ubiquitination of Tax. Tax-induced overexpression of TAB2 (but not TAB3) leads to constitutive TAK1 activation, which drives JNK-ATF2 but not IKK-NF-κB signaling.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, kinase assays, reporter assays\",\n      \"journal\": \"The Journal of biological chemistry / Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus kinase assays plus reporter, two independent papers (PMIDs 17626013, 17986383) with similar conclusions\",\n      \"pmids\": [\"17626013\", \"17986383\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TRIM30α promotes degradation of TAB2 and TAB3 through its RING domain E3 ubiquitin ligase activity. TRIM30α interacts with the TAB2-TAB3-TAK1 complex and negatively regulates TLR-mediated NF-κB activation via this degradation. Expression of TRIM30α is itself NF-κB-dependent, forming a negative feedback loop.\",\n      \"method\": \"Co-immunoprecipitation, protein degradation assay, siRNA knockdown, transgenic mouse, NF-κB reporter\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — co-IP, degradation assay, in vivo transgenic and siRNA knockdown, multiple orthogonal methods\",\n      \"pmids\": [\"18345001\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"NUMBL interacts with TAB2 via its PTB domain. NUMBL overexpression inhibits TNF-α- and IL-1β-induced NF-κB activation and impairs TAB2 binding to TRAF6 or RIP, and inhibits TRAF6 ubiquitination enhanced by TAB2.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation (in vitro and in vivo), NF-κB reporter, ubiquitination assay\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid plus reciprocal co-IP plus functional assay, single lab\",\n      \"pmids\": [\"18299187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Crystal structures of the TAB2 NZF domain bound to K63-linked di- and triubiquitin reveal that TAB2 binds adjacent ubiquitin moieties via two distinct binding sites. Both sites recognize the Ile44-centered hydrophobic patch on ubiquitin but do not contact the K63 isopeptide bond. The conformational constraints imposed by TAB2 on K63 dimers cannot be adopted by linear chains, explaining selectivity for K63 over linear ubiquitin chains.\",\n      \"method\": \"X-ray crystallography, mutagenesis of binding sites, ubiquitin-binding assay\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution crystal structures plus mutagenesis validation, independently confirmed by PMID:19927120\",\n      \"pmids\": [\"19935683\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Crystal structures of TAB2 and TAB3 NZF domains in complex with K63-linked diubiquitin at 1.18 and 1.40 Å resolution confirm two-site binding: distal ubiquitin recognized via conserved Thr-Phe dipeptide; proximal ubiquitin via a surface specific to TAB2/TAB3. Mutagenesis shows both sites are required for K63-linked diubiquitin binding.\",\n      \"method\": \"X-ray crystallography, mutagenesis, ubiquitin-binding assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution crystal structures with mutagenesis validation, corroborates PMID:19935683\",\n      \"pmids\": [\"19927120\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TAB2 was identified as a direct binding partner of RCAN1 by yeast two-hybrid. TAB2 recruits TAK1, TAB1, and calcineurin, forming a macromolecular signaling complex. TAK1 (activated via TAB1 and TAB2) phosphorylates RCAN1 at Ser94 and Ser136, converting RCAN1 from an inhibitor to a facilitator of calcineurin-NFAT signaling. In Tab2-deficient MEFs, the TAK1-TAB1-TAB2 and calcineurin-NFAT modules do not interact.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, in vitro kinase assay, site-directed mutagenesis, Tab2-deficient MEFs\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — yeast two-hybrid, in vitro kinase reconstitution, mutagenesis, genetic loss-of-function; multiple orthogonal methods in one rigorous study\",\n      \"pmids\": [\"19136967\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TAB2 functions as a scaffold protein that directly interacts with NLK and bridges TAK1 to NLK. The intermediate region (residues 292–417) of TAB2 is required for NLK binding. TAB2 mediates TAK1-dependent NLK activation and LEF1 polyubiquitylation, resulting in inhibition of canonical Wnt/β-catenin signaling. Wnt3a stimulation increases TAB2-NLK interaction and promotes TAK1-TAB2-NLK complex formation.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, deletion mutant analysis, luciferase reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with domain mapping, siRNA with functional readout, single lab\",\n      \"pmids\": [\"20194509\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Beclin 1 constitutively interacts with TAB2 and TAB3 via their coiled-coil domains. Upon autophagy induction, TAB2 and TAB3 dissociate from Beclin 1 and bind TAK1. Overexpression of TAB2/TAB3 suppresses autophagy, while their depletion triggers autophagy. This defines an autophagy-stimulatory switch where TAB2/TAB3 abandon inhibitory interactions with Beclin 1 to engage TAK1.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, autophagy assays, domain mapping (coiled-coil domain)\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — co-IP, domain mapping, siRNA/overexpression with autophagy functional readouts; multiple orthogonal methods\",\n      \"pmids\": [\"22081109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TAB2 interaction with TAK1 attenuates the ASK1-TAK1 interaction through competitive binding at the C-terminal TAB2-binding domain of TAK1, thereby reciprocally regulating both TAK1-NF-κB and ASK1-AP-1 signaling pathways.\",\n      \"method\": \"Co-immunoprecipitation, competitive binding assays, kinase assays, reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with competition assay and functional reporter assay, single lab\",\n      \"pmids\": [\"22167179\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TAB2 undergoes SUMOylation at the conserved lysine 329, mediated by the SUMO E3 ligase PIAS3. Mutation of K329 blocks SUMOylation and enhances TAB2 activity as measured by AP-1 luciferase reporter assays, indicating that SUMOylation negatively regulates TAB2 activity.\",\n      \"method\": \"SUMOylation assay, Ubc9 fusion analysis, site-directed mutagenesis (K329), co-immunoprecipitation with PIAS3, AP-1 reporter\",\n      \"journal\": \"Molecular and cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis of SUMOylation site with functional readout, co-IP with E3 ligase, single lab\",\n      \"pmids\": [\"24096733\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TRIM38 constitutively interacts with TAB2 and TAB3 and promotes their lysosome-dependent degradation, independent of TRIM38's E3 ubiquitin ligase activity. TRIM38 deficiency abolishes TAB2 translocation to the lysosome, increases TAB2 levels, and enhances TAK1 activation after TNF-α and IL-1β stimulation.\",\n      \"method\": \"Co-immunoprecipitation, lysosomal inhibitor assays, TRIM38 knockout cells, TRIM38 RING-domain mutant\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — co-IP, lysosomal pathway assay, knockout cells with specific kinase activation readout, domain mutant; multiple orthogonal methods\",\n      \"pmids\": [\"24434549\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Enterovirus 71 3C protease cleaves TAB2 at Q113-S114, requiring protease activity (abolished by H40D or C147S active-site substitutions). 3C interacts with TAB2 and TAK1, inhibiting NF-κB activation. Overexpression of TAB2 inhibits EV71 replication, while cleaved fragments have no effect.\",\n      \"method\": \"Co-immunoprecipitation, protease active-site mutagenesis, cleavage-site mapping, overexpression rescue assay\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — active-site mutagenesis, cleavage-site mapping, functional rescue experiment; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"24942571\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"RBCK1 physically interacts with TAB2 and TAB3 and facilitates their degradation through a proteasome-dependent process, negatively regulating TNF- and IL-1-induced NF-κB activation.\",\n      \"method\": \"Co-immunoprecipitation, proteasome inhibitor assay, siRNA knockdown, NF-κB reporter\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus proteasomal degradation assay plus siRNA functional readout, single lab\",\n      \"pmids\": [\"17449468\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"RNF4 interacts with the TAK1-TAB2-TAB3 complex (but not TAB1) and specifically down-regulates TAB2 through a lysosomal pathway, negatively regulating NF-κB signaling.\",\n      \"method\": \"Co-immunoprecipitation, lysosomal inhibitor assay, siRNA knockdown, NF-κB reporter\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, lysosomal pathway assay, siRNA functional readout; single lab\",\n      \"pmids\": [\"26299341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TRIM22 interacts with TAB2 and promotes its degradation, negatively regulating the TRAF6-stimulated NF-κB pathway. The RING domain of TRIM22 is required for these effects.\",\n      \"method\": \"Co-immunoprecipitation, protein degradation assay, RING-domain deletion mutant, NF-κB reporter\",\n      \"journal\": \"Virologica Sinica\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, domain mutant, degradation assay with functional readout; single lab\",\n      \"pmids\": [\"23818111\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TAB2 interacts with estrogen receptor alpha (ERα) through a central domain (residues adjacent to MEKK1 phosphorylation sites, distinct from the NZF and CUE domains). This interaction dismisses NCoR corepressor from ERα on target gene regulatory regions, contributing to tamoxifen resistance. siRNA knockdown of TAB2 restores antiproliferative response to tamoxifen in resistant breast cancer cells.\",\n      \"method\": \"Co-immunoprecipitation, pull-down with recombinant proteins, competition assay, domain mapping, siRNA knockdown, cell proliferation assay\",\n      \"journal\": \"PloS one / Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — recombinant protein pull-down with domain mapping, siRNA functional assay; two papers from same lab\",\n      \"pmids\": [\"27992601\", \"22249258\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"IL-1β can activate the TAB1-TAK1 heterodimer in TAB2/TAB3 double knockout cells, but this activation requires TRAF6 expression and Ubc13 (K63-Ub chain synthesis). In TAB2/3 DKO cells, early NF-κB and p38α activation is normal but is transient, and JNK1/2 and p38γ activation is greatly reduced. An ubiquitin-binding-defective mutant of TAB2 cannot restore signaling to TAB1/2/3 triple KO cells, confirming that K63-Ub chain binding by TAB2 is required for sustained/full TAK1 signaling.\",\n      \"method\": \"TAB2/TAB3 double knockout cells, TAB1/2/3 triple knockout cells, ubiquitin-binding mutant reconstitution, kinase assays, siRNA knockdown\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic knockouts, ubiquitin-binding mutant rescue, kinase assays with multiple pathway readouts; systematic mechanistic dissection\",\n      \"pmids\": [\"28507161\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Multiple GPCR agonists (thrombin, histamine) activate p38 MAPK via a non-canonical, TAB1-TAB2-dependent pathway (rather than canonical MKK3/6) in endothelial cells. In different endothelial cell types, either TAB1-TAB2 or TAB1-TAB3, or both, are required for GPCR-stimulated p38 autophosphorylation and IL-6 production.\",\n      \"method\": \"siRNA knockdown of TAB1, TAB2, TAB3; phosphorylation assays; IL-6 production assay; multiple endothelial cell types\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown with multiple cell types and phosphorylation readouts, single lab\",\n      \"pmids\": [\"30760523\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"USP15 deubiquitinates K48-linked ubiquitin chains from TAB2 (and independently inhibits lysosome-associated TAB2 degradation via a deubiquitinase-independent mechanism), thereby stabilizing TAB2, enhancing TAK1-TAB complex integrity, and potentiating NF-κB activation following TNF-α and IL-1β stimulation.\",\n      \"method\": \"Co-immunoprecipitation, deubiquitination assay, lysosomal inhibitor assay, siRNA knockdown/overexpression, NF-κB reporter\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — deubiquitination assay, co-IP, dual-pathway degradation assay; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"31903660\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Crystal structure of TAB2 NZF in complex with K6-linked diubiquitin at 1.99 Å resolution reveals that TAB2-NZF simultaneously contacts distal and proximal ubiquitin moieties of K6-Ub2. Structural comparison with K63-Ub2 complex shows similar binding mechanism except for flexibility in the C-terminal region of the distal ubiquitin, which accounts for dual K6/K63 specificity.\",\n      \"method\": \"X-ray crystallography, structural comparison, mutagenesis\",\n      \"journal\": \"Biophysical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — high-resolution crystal structure with structural comparison to previously solved K63 complex; single lab\",\n      \"pmids\": [\"34242591\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Cardiomyocyte-specific deletion of TAB2 (but not TAB3) in mice causes dilated cardiomyopathy with massive apoptotic and necroptotic cell death. TAB2 critically mediates RIPK1 phosphorylation at Ser321 via a TAK1-dependent mechanism, preventing RIPK1 kinase activation and formation of RIPK1-FADD-caspase-8 apoptotic and RIPK1-RIPK3 necroptotic complexes. Genetic inactivation of RIPK1 (Ripk1-K45A knockin) rescues cardiac remodeling in Tab2-deficient mice.\",\n      \"method\": \"Cardiomyocyte-specific TAB2 knockout, RIPK1 phosphorylation assay, RIPK1-K45A knockin rescue, complex immunoprecipitation, apoptosis/necroptosis assays\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout with TAK1 activation rescue, RIPK1 phosphorylation assay, genetic rescue with RIPK1-K45A knockin; multiple orthogonal in vivo and in vitro methods\",\n      \"pmids\": [\"34990405\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"USP25 deubiquitinates K63-specific polyubiquitin chains from TAB2, restricting NF-κB and MAPK signaling activation. AAV9-mediated TAB2 knockdown ameliorates ischemic stroke injury and abolishes the effect of USP25 deletion, placing USP25-TAB2 axis in neuroinflammatory regulation.\",\n      \"method\": \"Co-immunoprecipitation, K63-deubiquitination assay, AAV9-mediated knockdown in vivo, NF-κB/MAPK signaling assays\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — deubiquitination assay, in vivo AAV9 knockdown rescue, co-IP; single lab\",\n      \"pmids\": [\"37587766\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"RNF99 promotes K48-linked ubiquitination of TAB2 at lysine 611, leading to proteasomal degradation of TAB2 and negative regulation of TLR-mediated NF-κB and MAPK signaling. RNF99 knockout mice show enhanced TLR-mediated cytokine production.\",\n      \"method\": \"Co-immunoprecipitation, K48-ubiquitination assay, site-directed mutagenesis (K611), RNF99 knockout mouse, proteasomal inhibitor assay\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — site-specific ubiquitination mutagenesis, knockout mouse, proteasomal pathway assay, multiple orthogonal methods\",\n      \"pmids\": [\"36681779\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TAB2 and TAB3 are redundantly required for TLR-mediated cytokine production (TNF-α, IL-6) in macrophages. TAB2/TAB3 double-deficient macrophages show significantly impaired NF-κB and MAPK pathway activation, and severely compromised IκBζ expression at both protein and mRNA levels, thereby impeding IL-6 production.\",\n      \"method\": \"TAB2/TAB3 double knockout macrophages (improved mouse model), cytokine assays, NF-κB and MAPK signaling assays, IκBζ expression analysis\",\n      \"journal\": \"International immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — improved double knockout model with multiple signaling readouts; directly addresses and resolves prior conflicting result\",\n      \"pmids\": [\"38567483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"LSDV001 viral protein interacts with TAK1 and TAB2/TAB3 and promotes assembly of the TAK1-TAB2/3 complex, leading to enhanced IKK-dependent NF-κB activation and inflammatory cytokine induction. LSDV001-deficient virus has attenuated NF-κB activation and reduced pathology.\",\n      \"method\": \"Co-immunoprecipitation, NF-κB reporter, virus deletion mutant (LSDVΔ001), in vivo infection model\",\n      \"journal\": \"mBio\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, viral deletion mutant with functional readout and in vivo phenotype; single lab\",\n      \"pmids\": [\"40852992\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TAB2 is a scaffold/adaptor protein that bridges the upstream ubiquitin-signaling machinery to the kinase TAK1 by binding K63- (and K6-) linked polyubiquitin chains through its C-terminal NZF zinc-finger domain, thereby recruiting and activating the TAK1 kinase complex downstream of IL-1R, TNFR, TLRs, RANK, and other immune receptors to drive NF-κB, JNK, and p38 MAPK signaling; TAB2 additionally inhibits autophagy by sequestering Beclin 1, scaffolds TAK1-NLK for Wnt pathway repression, mediates RIPK1 phosphorylation at Ser321 to suppress cardiomyocyte necroptosis/apoptosis, and interacts with estrogen receptor α to modulate corepressor dismissal, while its activity and stability are regulated by multiple E3 ubiquitin ligases (TRIM30α, TRIM38, RBCK1, RNF4, RNF99) and deubiquitinases (USP15, USP25) that target it for proteasomal or lysosomal degradation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TAB2 is a ubiquitin-binding scaffold/adaptor protein that couples upstream immune-receptor signaling to activation of the kinase TAK1, driving NF-\\u03baB, JNK, and p38 MAPK responses downstream of IL-1R, TNFR, TLRs, RANK, and Edar [#0, #3, #4, #10]. Upon IL-1 stimulation, TAB2 translocates from the membrane to the cytosol in an IRAK-dependent manner and bridges TAK1 to TRAF6, nucleating the TRAF6\\u2013TAK1\\u2013TAB1\\u2013TAB2 complex whose assembly and disassembly govern TAK1 activation [#0, #1, #2]. The central mechanistic basis is the C-terminal NZF zinc-finger domain, which binds preferentially to K63- (and K6-) linked polyubiquitin chains; crystal structures show two-site recognition of adjacent ubiquitin moieties via the Ile44 hydrophobic patch, with conformational constraints that select against linear chains, and mutations abolishing ubiquitin binding eliminate TAK1/IKK activation [#7, #17, #18, #33]. TAB2 is functionally redundant with its paralog TAB3: single deletion leaves IL-1/TNF signaling largely intact, whereas combined loss impairs sustained TAK1, NF-\\u03baB, and MAPK activation, I\\u03baB\\u03b6 expression, and macrophage cytokine production, with K63-ubiquitin binding by TAB2 required for full/sustained signaling [#6, #9, #30, #37]. Beyond canonical inflammatory signaling, TAB2 scaffolds TAK1 to NLK to repress Wnt/\\u03b2-catenin signaling [#20], sequesters Beclin 1 to restrain autophagy until TAB2/TAB3 switch to engage TAK1 [#21], and in cardiomyocytes mediates TAK1-dependent RIPK1 Ser321 phosphorylation that prevents apoptotic and necroptotic cell death; cardiomyocyte-specific TAB2 loss causes dilated cardiomyopathy rescued by RIPK1 kinase inactivation [#34]. TAB2 abundance and activity are tightly controlled by E3 ligases driving proteasomal or lysosomal degradation (TRIM30\\u03b1, TRIM38, RBCK1, RNF4, TRIM22, RNF99) and by deubiquitinases (USP15, USP25) that stabilize it and potentiate signaling [#15, #24, #26, #27, #28, #32, #35, #36].\"\n,\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Established TAB2 as the adaptor that physically links TAK1 to TRAF6 in IL-1 signaling, defining its core scaffolding role in NF-\\u03baB/JNK activation.\",\n      \"evidence\": \"Co-IP, dominant-negative overexpression, and subcellular fractionation in IL-1-stimulated cells\",\n      \"pmids\": [\"10882101\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the molecular determinant of the TRAF6 interaction\", \"Did not establish whether the link is direct or ubiquitin-mediated\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Resolved the temporal order of complex assembly, showing IRAK-dependent membrane recruitment of TRAF6 to pre-formed TAK1-TAB1-TAB2 followed by phosphorylation and cytosolic translocation.\",\n      \"evidence\": \"Sequential co-IP, subcellular fractionation, and phosphorylation assays in IRAK-deficient cells\",\n      \"pmids\": [\"11259596\", \"12242293\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the signal triggering complex dissociation\", \"Phosphorylation sites on TAB2 not mapped\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Extended TAB2's adaptor role beyond IL-1R to RANK signaling, generalizing it across immune receptors.\",\n      \"evidence\": \"Co-IP and dominant-negative kinase assays in RANK-transfected and RAW264.7 cells\",\n      \"pmids\": [\"11809792\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address redundancy with TAB3 in this context\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Knockout mice revealed TAB2 is dispensable for IL-1 signaling in fibroblasts but essential for fetal liver survival, separating signaling redundancy from an anti-apoptotic role.\",\n      \"evidence\": \"TAB2 knockout mouse with embryonic phenotyping and MEF signaling assays\",\n      \"pmids\": [\"12556483\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of the anti-apoptotic liver function not defined\", \"Redundant factor compensating in MEFs not yet identified\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identified TAB3 as a functionally redundant paralog, explaining why single TAB2 loss is tolerated and that both are ubiquitinated via TRAF6.\",\n      \"evidence\": \"siRNA double knockdown, co-IP, and ubiquitination assays\",\n      \"pmids\": [\"14633987\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish the linkage type of TAB2/TAB3 ubiquitination\", \"Functional consequence of TAB2 ubiquitination unclear\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Defined the mechanistic core: the NZF zinc finger binds K63-linked polyubiquitin and this binding is necessary and sufficient (via domain swap) for TAK1/IKK activation.\",\n      \"evidence\": \"In vitro ubiquitin binding, mutagenesis, and heterologous domain-swap rescue with co-IP\",\n      \"pmids\": [\"15327770\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of K63 selectivity not yet resolved\", \"Physiological ubiquitinated targets only partly defined (RIP)\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Genetic dissection placed TAK1 as essential and TAB2/TAB1 as individually dispensable across TNFR1/IL-1R/TLR signaling, clarifying the division of labor in the complex.\",\n      \"evidence\": \"Conditional knockout MEFs with NF-\\u03baB/AP-1 reporter and kinase assays\",\n      \"pmids\": [\"16260493\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not test combined TAB2/TAB3 loss\", \"In vivo immune consequences not addressed\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Mapped reciprocal binding interfaces between TAB2 (residues 574\\u2013693) and TAK1 (residues 479\\u2013553), enabling a disrupting peptide that blocks signaling and osteoclast differentiation.\",\n      \"evidence\": \"Deletion mapping, co-IP, dominant-negative peptide, and osteoclast differentiation assays\",\n      \"pmids\": [\"17158449\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not provide atomic structure of the interface\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Crystal structures explained K63 selectivity by showing two-site recognition of adjacent ubiquitins via the Ile44 patch with conformational constraints incompatible with linear chains.\",\n      \"evidence\": \"X-ray crystallography of NZF\\u2013K63 di/triubiquitin complexes with mutagenesis\",\n      \"pmids\": [\"19935683\", \"19927120\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address binding to other non-K63 linkages such as K6\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Revealed a non-inflammatory scaffolding role, recruiting calcineurin/RCAN1 to TAK1 so that TAK1 phosphorylates RCAN1 to facilitate calcineurin-NFAT signaling.\",\n      \"evidence\": \"Yeast two-hybrid, in vitro kinase reconstitution, mutagenesis, and Tab2-deficient MEFs\",\n      \"pmids\": [\"19136967\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological tissue context of this module not defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Extended TAB2 scaffolding to Wnt repression by bridging TAK1 to NLK to drive LEF1 ubiquitylation and inhibit \\u03b2-catenin signaling.\",\n      \"evidence\": \"Co-IP, domain mapping (residues 292\\u2013417), siRNA, and luciferase reporter\",\n      \"pmids\": [\"20194509\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"In vivo relevance to Wnt-dependent processes not tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identified a TAB2/TAB3-Beclin 1 interaction that restrains autophagy, with a switch in which TAB2/TAB3 dissociate from Beclin 1 to engage TAK1 upon autophagy induction.\",\n      \"evidence\": \"Co-IP, coiled-coil domain mapping, siRNA/overexpression with autophagy readouts\",\n      \"pmids\": [\"22081109\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trigger that releases TAB2 from Beclin 1 not defined\", \"Direct effect on Beclin 1 function unresolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Established degradative regulation of TAB2 by demonstrating TRIM30\\u03b1-mediated degradation in an NF-\\u03baB-dependent negative-feedback loop.\",\n      \"evidence\": \"Co-IP, degradation assay, siRNA, and transgenic mouse with NF-\\u03baB reporter\",\n      \"pmids\": [\"18345001\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Ubiquitin linkage on TAB2 not specified\", \"Degradation route (proteasome vs lysosome) not defined here\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Distinguished lysosomal from proteasomal turnover, showing TRIM38 drives ligase-activity-independent lysosomal degradation of TAB2 to dampen TAK1 activation.\",\n      \"evidence\": \"Co-IP, lysosomal inhibitor assay, TRIM38 knockout cells, and RING-domain mutant\",\n      \"pmids\": [\"24434549\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trafficking machinery routing TAB2 to lysosomes not defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defined site-specific proteasomal control via RNF99-mediated K48 ubiquitination of TAB2 at Lys611 with an in vivo TLR hyperresponsiveness phenotype.\",\n      \"evidence\": \"Co-IP, K48-ubiquitination assay, K611 mutagenesis, and RNF99 knockout mouse\",\n      \"pmids\": [\"36681779\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stimulus controlling RNF99 engagement of TAB2 not defined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identified deubiquitinase counter-regulation, showing USP15 (K48 removal plus a DUB-independent block of lysosomal degradation) and later USP25 (K63 removal) tune TAB2 stability and signaling output.\",\n      \"evidence\": \"Deubiquitination assays, co-IP, lysosomal inhibitor assays, and NF-\\u03baB reporter; USP25 with in vivo AAV9 knockdown\",\n      \"pmids\": [\"31903660\", \"37587766\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab per DUB\", \"Interplay between opposing E3/DUB activities not reconstituted\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Quantified the contribution of K63-ubiquitin binding to signaling duration, showing TAB2/TAB3 are needed for sustained (not initial) TAK1 activation and that the binding-defective mutant fails to rescue triple-knockout cells.\",\n      \"evidence\": \"TAB2/TAB3 double- and TAB1/2/3 triple-knockout cells with ubiquitin-binding mutant reconstitution and kinase assays\",\n      \"pmids\": [\"28507161\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism converting ubiquitin binding into sustained kinase output not fully defined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Revealed a cardioprotective cell-death function in which TAB2 mediates TAK1-dependent RIPK1 Ser321 phosphorylation to suppress apoptosis and necroptosis, with loss causing dilated cardiomyopathy.\",\n      \"evidence\": \"Cardiomyocyte-specific knockout, RIPK1 phosphorylation assay, RIPK1-K45A knockin rescue, and death-complex IP\",\n      \"pmids\": [\"34990405\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TAB2's ubiquitin binding is required for RIPK1 regulation not isolated\", \"Generality beyond cardiomyocytes untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Resolved earlier conflicting redundancy data with an improved double-knockout model, confirming TAB2/TAB3 are redundantly required for TLR-driven NF-\\u03baB/MAPK activation, I\\u03baB\\u03b6 expression, and IL-6 production in macrophages.\",\n      \"evidence\": \"TAB2/TAB3 double-knockout macrophages with cytokine and signaling assays and I\\u03baB\\u03b6 analysis\",\n      \"pmids\": [\"38567483\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which TAB2/TAB3 control I\\u03baB\\u03b6 transcription not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the diverse non-canonical TAB2 functions (calcineurin-NFAT, NLK-Wnt, Beclin 1-autophagy, RIPK1 cell death, ER\\u03b1 corepressor dismissal) are coordinated with its canonical ubiquitin-dependent TAK1 scaffolding, and which require NZF ubiquitin binding, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unifying model linking ubiquitin binding to the non-TAK1 functions\", \"Tissue- and stimulus-specific partitioning of TAB2 functions not mapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0043130\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 7, 19, 20]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 2]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 3, 4, 37]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 7, 31]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [21]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [34]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [15, 24, 36]}\n    ],\n    \"complexes\": [\n      \"TAK1-TAB1-TAB2 kinase complex\",\n      \"TRAF6-TAK1-TAB1-TAB2 complex\"\n    ],\n    \"partners\": [\n      \"TAK1\",\n      \"TAB1\",\n      \"TRAF6\",\n      \"NLK\",\n      \"BECN1\",\n      \"RIPK1\",\n      \"RCAN1\",\n      \"TRAF2\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}